Stemcentrx
-
2008
Company Description
Stemcentrx develops therapies and diagnostics for cancer patients.
Stem CentRx is combining scientific talent from the world’s leading academic labs and enterprises, a stem cell-centric philosophy, and an approach that embraces new technologies and paradigms to discover and develop novel therapies and diagnostics for patients with solid tumors. The company is backed by premier venture investors ARTIS Ventures and Founders Fund. Specialties Solid Tumor Cancer Stem Cell Discovery & Targeted Therapeutics
-
Manufacturer:
Science and Engineering -
Formed:
2008 -
Founders:
Scott J. Dylla -
Company Website:
-
Company E-mail:
-
Company Address:
450 East Jamie Court, 3rd FloorSouth San Francisco, CAUnited States -
CEO:
- Scott J. Dylla
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits